Drug
Sulindac sulfone clinical trials
Also written exisulind and Aptosyn.
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2002 (4)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 8
Alliance for Clinical Trials in Oncology (2) · Astellas Pharma Inc (2) · Eastern Cooperative Oncology Group (1) · University of Washington (1) · National Cancer Institute (NCI) (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · University of Utah (1)
Often tested with
Tested in the same studies.
Carboplatin (2) · Gemcitabine (1) · Etoposide (1) · Docetaxel (1) · Estramustine (1) · Capecitabine (1)
Studies
Open first, then newest update. How each study uses sulindac sulfone is read from its arms, and is right about nine times in ten.
Testing it · 10
- Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedPhase 2Eastern Cooperative Oncology GroupNCT00041314Written as exisulind
- Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate CancerCompletedPhase 2University of WashingtonNCT00283803Written as Exisulind
- Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00041054Written as exisulind
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00052845Written as exisulind
- Exisulind in Preventing Polyps in Patients With Familial Adenomatous PolyposisWithdrawnPhase 2/3University of UtahNCT00026468Written as exisulind
- Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT00078910Written as exisulind
- Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedPhase 1/2M.D. Anderson Cancer CenterNCT00037609Written as Exisulind
- A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsCompletedPhase 3Astellas Pharma IncNCT00085826Written as Exisulind
- Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedPhase 1/2Astellas Pharma IncNCT00072618Written as Exisulind
- Exisulind Versus Placebo After Surgical Removal of the ProstateCompletedPhase 2Mayo ClinicNCT00166426Written as Exisulind
Codes
What other systems call sulindac sulfone · ClinicalTrials.gg INT002816
- MeSH (NLM) C025463sulindac sulfoneConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) K619IIG2R9EXISULINDConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C025463 | sulindac sulfone | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | K619IIG2R9 | EXISULIND | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.